People not taking HIV treatment feel under pressure to ‘do the right thing’

Australian people living with HIV who have chosen not to take antiretrovirals and who have doubts about HIV medicine report feeling excluded and silenced within HIV organisations and communities, according to a qualitative study published online ahead of print by Medical Anthropology Quarterly.

In general, the interviewees did not deny the benefits of antiretrovirals, but did not yet feel ready to make a commitment to start a lifelong regimen of medication. They were aware that good adherence is vital but may be challenging, and also of the potential of all prescribed medications to do harm as well as good. Given these concerns and hesitations, pressure to take treatment for the benefit of the wider community did not sit easily with the interviewees.

Asha Persson and colleagues from the University of New South Wales designed a study which aimed to understand the views and experiences of people not using HIV treatment at a time of growing policy emphasis on treatment uptake. They conducted in-depth, qualitative interviews with 27 people living with HIV who were not taking HIV treatment at the time of their interviews (conducted between 2012 and 2014). While ten interviewees had never taken HIV treatment, the others had previously done so for a short period of time or for a specific purpose, such as pregnancy. The sample included 19 gay men, four heterosexual women, three heterosexual men and one bisexual man.

Persson examines the interviewees’ stories in the context of the anthropological concept of ‘pharmaceutical citizenship’. According to this concept, pharmaceutical medications are seen as having the promise of allowing individuals to fully participate in society, in other words to be more active citizens. People who may have been marginalised by poor mental health, physical incapacity, infectious disease or a stigmatised health condition can be re-integrated.

To give an example of pharmaceutical citizenship related to HIV, a previous study showed how an awareness of the impact of HIV treatment on prevention was helpful for couples in which one person has HIV and the other does not. Anxieties about the risk of HIV transmission were receding, allowing the couples to experience their relationships as ‘normal’ and safe.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)